Drug use-results survey of ombitasvir/paritaprevir/ritonavir coformulated tablet in patients with genotype 1 chronic hepatitis C with or without compensated cirrhosis

Kanzo ◽

10.2957/kanzo.62.690 ◽

2021 ◽

Vol 62 (11) ◽

pp. 690-702

Author(s):

Satoshi Mochida ◽

Ryuta Sakuma ◽

Ryo Nakajima ◽

Takeshi Kawaberi ◽

Namiki Izumi

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Drug Use ◽

Chronic Hepatitis C ◽

Compensated Cirrhosis

Download Full-text

EXPEDITION-I: efficacy and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus genotype 1, 2, 4, 5 or 6 infection and compensated cirrhosis

Journal of Hepatology ◽

10.1016/s0168-8278(17)30269-6 ◽

2017 ◽

Vol 66 (1) ◽

pp. S3-S4 ◽

Author(s):

X. Forns ◽

S. Lee ◽

J. Valdes ◽

S. Lens ◽

R. Ghalib ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Efficacy And Safety ◽

Virus Genotype ◽

Compensated Cirrhosis ◽

Chronic Hepatitis C Virus

Download Full-text

1223Ledipasvir/Sofosbuvir is Safe and Effective as a Single-Tablet-Regimen for Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus, Including those with Compensated Cirrhosis

Open Forum Infectious Diseases ◽

10.1093/ofid/ofu051.111 ◽

2014 ◽

Vol 1 (suppl_1) ◽

pp. S42-S42

Author(s):

Mark Sulkowski ◽

Kris Kowdley ◽

Peter Ruane ◽

Trevor Hawkins ◽

Richard Elion ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Compensated Cirrhosis ◽

Single Tablet Regimen ◽

Chronic Hepatitis C Virus

Download Full-text

EXPEDITION-I: Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults with Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis

Gastroenterology ◽

10.1016/s0016-5085(17)33583-7 ◽

2017 ◽

Vol 152 (5) ◽

pp. S1061 ◽

Author(s):

Xavier Forns ◽

Sam Lee ◽

Joaquin M. Valdes ◽

Sabela Lens ◽

Reem Ghalib ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Efficacy And Safety ◽

Virus Genotype ◽

Compensated Cirrhosis ◽

Chronic Hepatitis C Virus

Download Full-text

952 Outcomes of Glecaprevir-Pibrentasvir Treatment for Chronic Hepatitis C of Any Genotype (1-6, Mixed) in Patients With Compensated Cirrhosis: Real World Results From a Safety Net Hospital

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000593344.46084.42 ◽

2019 ◽

Vol 114 (1) ◽

pp. S552-S553

Author(s):

Gurbir Sehmbey ◽

Gerard Quigley ◽

Tessa Bowie ◽

Sharad Bellapravalu ◽

Abdul Nadir ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Compensated Cirrhosis ◽

Safety Net Hospital

Download Full-text

JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study

Journal of Gastroenterology ◽

10.1007/s00535-020-01672-0 ◽

2020 ◽

Vol 55 (6) ◽

pp. 640-652

Author(s):

Tetsuo Takehara ◽

Kazuaki Chayama ◽

Masayuki Kurosaki ◽

Hiroshi Yatsuhashi ◽

Yasuhito Tanaka ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Japanese Patients ◽

Omega 3 ◽

Virus Genotype ◽

Compensated Cirrhosis ◽

Chronic Hepatitis C Virus

Download Full-text

Predictors of relapse in genotype 1 patients treated with PegIFN-alfa2b and ribavirin due to chronic hepatitis C within a large German multicentric observational study

Zeitschrift für Gastroenterologie ◽

10.1055/s-0028-1089437 ◽

2008 ◽

Vol 46 (09) ◽

Author(s):

S Mauss ◽

D Hueppe ◽

M Manns ◽

G Teuber ◽

T Dahhan ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Observational Study ◽

Chronic Hepatitis C ◽

Download Full-text

IL28B genetic variation and ratio of y-GT/ALT as predictors for virological response in chronic hepatitis C virus genotype 1 infected patients

Zeitschrift für Gastroenterologie ◽

10.1055/s-0031-1295892 ◽

2012 ◽

Vol 50 (01) ◽

Author(s):

A Amanzada ◽

S Schneider ◽

F Moriconi ◽

M Blaschke ◽

T Suermann ◽

...

Keyword(s):

Genetic Variation ◽

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virological Response ◽

Virus Genotype ◽

Chronic Hepatitis C Virus

Download Full-text

Treatment of chronic hepatitis C Genotype 1 (G1) infection with boceprevir (Victrelis®) in the German real-life setting: First results for treatment-naïve patients from the Novus observational study

Zeitschrift für Gastroenterologie ◽

10.1055/s-0033-1352957 ◽

2013 ◽

Vol 51 (08) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Observational Study ◽

Chronic Hepatitis C ◽

Real Life ◽

Real Life Setting ◽

First Results ◽

Treatment Naïve

Download Full-text

Development of autoantibodies against “rings and rods”-associated IMPDH2 in chronic hepatitis C genotype 1 infection during protease inhibitor based triple therapy in a “real life” cohort

Zeitschrift für Gastroenterologie ◽

10.1055/s-0036-1597391 ◽

2016 ◽

Vol 54 (12) ◽

pp. 1343-1404

Author(s):

W Dammermann ◽

S Polywka ◽

I Dettmann ◽

S Mindorf ◽

L Komorowski ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Protease Inhibitor ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Real Life ◽

Download Full-text

Faculty Opinions recommendation of Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717952635.793458150 ◽

2012 ◽

Author(s):

Alex Thompson

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Dose Finding ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text